Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000472049 | SCV000545839 | uncertain significance | Autosomal recessive polycystic kidney disease | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with valine at codon 757 of the PKHD1 protein (p.Ile757Val). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and valine. This variant is present in population databases (rs777183511, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 406884). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002481409 | SCV002777816 | uncertain significance | Polycystic kidney disease 4 | 2022-03-11 | criteria provided, single submitter | clinical testing | |
Laboratory of Gastroenterology and Hepatology, |
RCV001844832 | SCV001876990 | uncertain significance | Autosomal dominant polycystic liver disease | 2021-09-01 | no assertion criteria provided | research | |
Natera, |
RCV000472049 | SCV002081040 | uncertain significance | Autosomal recessive polycystic kidney disease | 2018-12-19 | no assertion criteria provided | clinical testing |